In This Article:
As global markets rally with major indices reaching new highs, driven by optimism over potential trade deals and AI investments, investors are keenly observing the performance of growth stocks, which have recently outpaced their value counterparts. Amidst this buoyant environment, identifying undervalued stocks can be a strategic move for those looking to capitalize on discrepancies between market price and intrinsic value. Recognizing such opportunities often involves assessing a company's fundamentals against prevailing market conditions to determine its true worth.
Top 10 Undervalued Stocks Based On Cash Flows
Name | Current Price | Fair Value (Est) | Discount (Est) |
Argan (NYSE:AGX) | US$137.36 | US$273.30 | 49.7% |
Subros (BSE:517168) | ₹600.55 | ₹1197.01 | 49.8% |
Guangdong Mingyang ElectricLtd (SZSE:301291) | CN¥50.90 | CN¥101.57 | 49.9% |
74Software (ENXTPA:74SW) | €26.50 | €52.89 | 49.9% |
Solum (KOSE:A248070) | ₩18950.00 | ₩37756.10 | 49.8% |
Dynavox Group (OM:DYVOX) | SEK68.20 | SEK136.07 | 49.9% |
GemPharmatech (SHSE:688046) | CN¥13.06 | CN¥26.02 | 49.8% |
Shandong Weigao Orthopaedic Device (SHSE:688161) | CN¥25.57 | CN¥51.06 | 49.9% |
St. James's Place (LSE:STJ) | £9.31 | £18.53 | 49.8% |
Netum Group Oyj (HLSE:NETUM) | €2.82 | €5.63 | 49.9% |
Underneath we present a selection of stocks filtered out by our screen.
MicroPort NeuroScientific
Overview: MicroPort NeuroScientific Corporation focuses on the research, development, production, and sale of neuro-interventional medical devices both in China and internationally, with a market cap of HK$5.91 billion.
Operations: The company generates revenue of CN¥774.66 million from its surgical and medical equipment segment.
Estimated Discount To Fair Value: 49.2%
MicroPort NeuroScientific is trading at HK$10.24, significantly below its estimated fair value of HK$20.15, suggesting undervaluation based on cash flows. The company forecasts robust revenue growth of 21.4% annually, outpacing the Hong Kong market's 7.6%. Recent guidance indicates a net profit increase of up to 100% for 2024, driven by expanded hospital coverage and improved overseas revenue. However, its Return on Equity is expected to be modest at 14.5% in three years.
-
Dive into the specifics of MicroPort NeuroScientific here with our thorough financial health report.
TORIDOLL Holdings
Overview: TORIDOLL Holdings Corporation operates and manages restaurants in Japan and internationally, with a market cap of ¥325.03 billion.